Evidence map›Paper›PMID 31519807›Full record

ArticleJournal of cell science2019

The lncRNA

Luca Lo Piccolo, Hideki Mochizuki, Yoshitaka Nagai

Open access · hybridAbstract read
In one paragraph

Article in Journal of cell science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. From development to disease: the neuronal role of hnRNPs through the lens ofFrontiers in cell and developmental biology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Long Non-Coding RNAs inFrontiers in cellular and infection microbiology · 2022
    Article
  10. Article
  11. Review
  12. Article
  13. Amyotrophic Lateral Sclerosis Genes inInternational journal of molecular sciences · 2021
    Review
  14. Review
  15. Review
  16. Review
  17. RNA-binding proteins in tumor progression.Journal of hematology & oncology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Luca Lo PiccoloDepartment of Neurotherapeutics, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan lopiccolo@neurother.med.osaka-u.ac.jp nagai@neurother.med.osaka-u.ac.jp.ORCID 0000-0003-0558-356X
Hideki MochizukiDepartment of Neurology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
Yoshitaka NagaiDepartment of Neurotherapeutics, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan lopiccolo@neurother.med.osaka-u.ac.jp nagai@neurother.med.osaka-u.ac.jp.
The University of Osaka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long non-coding RNAs (lncRNAs) have structural and regulatory effects on RNA-binding proteins (RBPs). However, the mechanisms by which lncRNAs regulate the neurodegenerative-causative RBP like FUS protein remain poorly understood. Here, we show that knockdown of the

Indexed as

Protein Processing, Post-TranslationalProteolysisAnimalsDemethylationDrosophila melanogasterDrosophila ProteinsHeterogeneous-Nuclear Ribonucleoprotein Group F-HHumansProteasome Endopeptidase ComplexRNA-Binding Protein FUSRNA, Long NoncodingDrosophila ProteinsFUS protein, DrosophilaFUS protein, humanHeterogeneous-Nuclear Ribonucleoprotein Group F-HProteasome Endopeptidase ComplexRNA-Binding Protein FUSRNA, Long NoncodingArginine dimethylationDrosophilaFUS cellular localisationFUS toxicitylncRNAsNeurodegenerationPost-translation modificationRBP homeostasis

Identifiers

PMID31519807
PMCPMC6826006
OpenAlexW2972886431

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.